SI-BONE, Inc. (SIBN) stock
SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3046% above fair value
$23.54+0.38 (+1.64%)
Close on Nov 18, 2026Market cap $1.06BP/E –Yield 0.00%
Si-Bone revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Si-Bone's revenue for the twelve months ending Jun 30, 2026 was $213.60M, up 15.3% year over year. For fiscal 2025 it was $200.93M, up 20.2% from the year before. The highest annual figure on record is $200.93M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $200.93M | +20.2% |
| FY2024 | Dec 31, 2024 | $167.18M | +20.4% |
| FY2023 | Dec 31, 2023 | $138.89M | +30.5% |
| FY2022 | Dec 31, 2022 | $106.41M | +18.0% |
| FY2021 | Dec 31, 2021 | $90.15M | +22.8% |
| FY2020 | Dec 31, 2020 | $73.39M | +9.0% |
| FY2019 | Dec 31, 2019 | $67.30M | +21.5% |
| FY2018 | Dec 31, 2018 | $55.38M | +15.4% |
| FY2017 | Dec 31, 2017 | $47.98M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $56.01M | +15.2% |
| Q1 FY2026 | Mar 31, 2026 | $52.59M | +11.2% |
| Q4 FY2025 | Dec 31, 2025 | $56.35M | +15.0% |
| Q3 FY2025 | Sep 30, 2025 | $48.66M | +20.6% |
| Q2 FY2025 | Jun 30, 2025 | $48.63M | +21.7% |
| Q1 FY2025 | Mar 31, 2025 | $47.29M | +24.9% |
| Q4 FY2024 | Dec 31, 2024 | $49.00M | +26.1% |
| Q3 FY2024 | Sep 30, 2024 | $40.34M | +18.6% |
| Q2 FY2024 | Jun 30, 2024 | $39.97M | +20.0% |
| Q1 FY2024 | Mar 31, 2024 | $37.87M | +15.8% |
| Q4 FY2023 | Dec 31, 2023 | $38.86M | +21.6% |
| Q3 FY2023 | Sep 30, 2023 | $34.01M | +28.7% |
| Q2 FY2023 | Jun 30, 2023 | $33.31M | +30.2% |
| Q1 FY2023 | Mar 31, 2023 | $32.71M | +45.8% |
| Q4 FY2022 | Dec 31, 2022 | $31.95M | +26.6% |
| Q3 FY2022 | Sep 30, 2022 | $26.43M | +18.6% |
| Q2 FY2022 | Jun 30, 2022 | $25.59M | +15.3% |
| Q1 FY2022 | Mar 31, 2022 | $22.44M | +9.8% |
| Q4 FY2021 | Dec 31, 2021 | $25.23M | +13.9% |
| Q3 FY2021 | Sep 30, 2021 | $22.29M | +9.4% |
| Q2 FY2021 | Jun 30, 2021 | $22.19M | +58.0% |
| Q1 FY2021 | Mar 31, 2021 | $20.44M | +21.5% |
| Q4 FY2020 | Dec 31, 2020 | $22.14M | +11.8% |
| Q3 FY2020 | Sep 30, 2020 | $20.37M | +25.9% |
| Q2 FY2020 | Jun 30, 2020 | $14.05M | -13.9% |
| Q1 FY2020 | Mar 31, 2020 | $16.82M | +12.2% |
| Q4 FY2019 | Dec 31, 2019 | $19.81M | +26.8% |
| Q3 FY2019 | Sep 30, 2019 | $16.18M | +20.9% |
| Q2 FY2019 | Jun 30, 2019 | $16.32M | +19.4% |
| Q1 FY2019 | Mar 31, 2019 | $14.99M | +17.9% |
| Q4 FY2018 | Dec 31, 2018 | $15.62M | +13.5% |
| Q3 FY2018 | Sep 30, 2018 | $13.38M | +14.5% |
| Q2 FY2018 | Jun 30, 2018 | $13.66M | – |
| Q1 FY2018 | Mar 31, 2018 | $12.71M | – |
| Q4 FY2017 | Dec 31, 2017 | $13.77M | – |
| Q3 FY2017 | Sep 30, 2017 | $11.68M | – |
See a number that looks wrong?